Understanding the differences among inotropes

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine

(2014) Maurizio Cecconi et al.   INTENSIVE CARE MEDICINE

Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study

(2013) Glenn Hernandez et al.   INTENSIVE CARE MEDICINE

The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis

(2013) Romain Pirracchio et al.   PLoS One

Cardiac inotropes: current agents and future directions

(2011) G. Hasenfuss et al.   EUROPEAN HEART JOURNAL

Levosimendan: Molecular mechanisms and clinical implications

(2011) Zoltán Papp et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

(2011) John GF Cleland et al.   LANCET

Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods

(2010) Alexandre Mebazaa et al.   INTENSIVE CARE MEDICINE

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

(2009) Alexandre Mebazaa et al.   EUROPEAN JOURNAL OF HEART FAILURE